Dianthus Therapeutics (DNTH) Non-Current Deferred Tax Liability (2017 - 2022)

Dianthus Therapeutics' Non-Current Deferred Tax Liability history runs 4 years deep, the most recent figure standing at $949000.0 for Q4 2022.

• In Q4 2022, Non-Current Deferred Tax Liability fell 18.26% year-over-year to $949000.0; the TTM figure through Dec 2022 stood at $949000.0 (down 18.26% YoY), while the FY2022 annual figure was $949000.0, down 18.26% from the prior year.
• Non-Current Deferred Tax Liability for Q4 2022 stood at $949000.0, down from $1.2 million in the prior quarter.
• The five-year high for Non-Current Deferred Tax Liability was $1.2 million in Q4 2021, with the low at $361000.0 in Q4 2018.
• The 3-year median for Non-Current Deferred Tax Liability is $949000.0 (2022), against an average of $823666.7.
• The sharpest annual moves came in 2018 and 2022: Non-Current Deferred Tax Liability soared 684.78% in 2018, then dropped 18.26% in 2022.
• Dianthus Therapeutics' Non-Current Deferred Tax Liability stood at $361000.0 in 2018, then soared by 221.61% to $1.2 million in 2021, then retreated by 18.26% to $949000.0 in 2022.
• Business Quant data shows DNTH's Non-Current Deferred Tax Liability at $949000.0 in Q4 2022, $1.2 million in Q4 2021, and $361000.0 in Q4 2018.